K
v
ire
.com
←
Back
Night
Docs
Library
Review
…
Author
Steven A. Rosenberg
also known as Rosenberg, Steven, Rosenberg, Steven A., S A Rosenberg
National Institutes of Health · National Cancer Institute · Center for Cancer Research · California Institute of Technology
About this author
Works
1,554
Cited by
197,312
h-index
219
i10
892
ORCID ↗
Top papers
Cancer immunotherapy: moving beyond current vaccines
Steven A. Rosenberg, James C. Yang, Nicholas P. Restifo
·
2004
·
Nature Medicine
↗ 2,956
OA
T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial
Daniel W Lee, James N. Kochenderfer, Maryalice Stetler‐Stevenson, et al.
·
2014
·
The Lancet
↗ 2,926
Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor Lymphocytes
Mark E. Dudley, John R. Wunderlich, Paul F. Robbins, et al.
·
2002
·
Science
↗ 2,805
OA
A Progress Report on the Treatment of 157 Patients with Advanced Cancer Using Lymphokine-Activated Killer Cells and Interleukin-2 or High-Dose Interleukin-2 Alone
Steven A. Rosenberg, Michael T. Lotze, Linda Muul, et al.
·
1987
·
New England Journal of Medicine
↗ 2,763
A Randomized Trial of Bevacizumab, an Anti–Vascular Endothelial Growth Factor Antibody, for Metastatic Renal Cancer
James Chih‐Hsin Yang, Leah Haworth, Richard M. Sherry, et al.
·
2003
·
New England Journal of Medicine
↗ 2,702
OA
Observations on the Systemic Administration of Autologous Lymphokine-Activated Killer Cells and Recombinant Interleukin-2 to Patients with Metastatic Cancer
Steven A. Rosenberg, Michael T. Lotze, Linda Muul, et al.
·
1985
·
New England Journal of Medicine
↗ 2,642
Cancer Regression in Patients After Transfer of Genetically Engineered Lymphocytes
Richard A. Morgan, Mark E. Dudley, John R. Wunderlich, et al.
·
2006
·
Science
↗ 2,566
OA
Case Report of a Serious Adverse Event Following the Administration of T Cells Transduced With a Chimeric Antigen Receptor Recognizing ERBB2
Richard A. Morgan, James C. Yang, Mio Kitano, et al.
·
2010
·
Molecular Therapy
↗ 2,505
OA
Adoptive cell transfer as personalized immunotherapy for human cancer
Steven A. Rosenberg, Nicholas P. Restifo
·
2015
·
Science
↗ 2,437
OA
Use of Tumor-Infiltrating Lymphocytes and Interleukin-2 in the Immunotherapy of Patients with Metastatic Melanoma
Steven A. Rosenberg, Beverly S. Packard, Paul Aebersold, et al.
·
1988
·
New England Journal of Medicine
↗ 2,330
Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes.
Elizabeth A. Grimm, A Mazumder, H Z Zhang, et al.
·
1982
·
The Journal of Experimental Medicine
↗ 2,209
OA
Durable Complete Responses in Heavily Pretreated Patients with Metastatic Melanoma Using T-Cell Transfer Immunotherapy
Steven A. Rosenberg, James Chih‐Hsin Yang, Richard M. Sherry, et al.
·
2011
·
Clinical Cancer Research
↗ 2,106
OA
Books
The transformed cell
1992
·
Orion Publishing Co
Surgical treatment of metastatic cancer
1987
·
Lippincott
AIDS
1997
·
Lippincott Williams & Wilkins
Cancer, principles & practice of oncology
2004
·
Lippincott Williams & Wilkins
Cancer, principles and practice of oncology
2001
·
Lippincott Williams & Wilkins
The transformed cell
1993
·
Avon
Serologic analysis of human cancer antigens
1980
·
Academic Press